https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35721 Wed 24 May 2023 12:21:56 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35216 .05). Conclusion: White matter changes after stroke may be localized rather than a global phenomenon.]]> Wed 06 Apr 2022 13:57:07 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48324 Tue 14 Mar 2023 16:40:44 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36655 Thu 28 Oct 2021 13:04:35 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35835 Thu 03 Feb 2022 12:21:17 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40206 Mon 08 Aug 2022 13:40:29 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30579 max) immediately prior to the 1 hour of task-specific training with the therapist. Recruitment, adherence, retention, participant acceptability, and adverse events will be recorded. Clinical outcome measures will be performed pre-randomisation at baseline, at completion of the training program, and at 1 and 6 months follow-up. Primary clinical outcome measures will be the Action Research Arm Test (ARAT) and the Wolf Motor Function Test (WMFT). If aerobic exercise prior to task-specific training is acceptable, and a future phase 3 randomised controlled trial seems feasible, it should be pursued to determine the efficacy of this combined intervention for people after stroke.]]> Fri 24 Aug 2018 09:07:00 AEST ]]>